Three new compounds containing the bis(triphenylphosphane)iminium cation (PPN+) with ClO4 −, BF4− and[AgCl2]− as counter anions have been synthesized and structurally characterized. The two derivatives with ClO4− and BF4− were found to be isostructural by single crystal X-ray diffraction. Interestingly, the three compounds show extremely potent antiproliferative effects against the human cancer cell line SKOV3. To gain insights into the possible mechanisms of biological action, several intracellular targets have been considered. Thus, DNA binding has been evaluated, as well as the effects of the compounds on the mitochondrial function. Furthermore, the compounds have been tested as possible inhibitors of the seleno-enzyme thioredoxin reductase.
Insights into the strong in-vitro anticancer effects for bis(triphenylphosphane)iminium compounds having perchlorate, tetrafluoridoborate and bis(chlorido)argentate anions
FOLDA, ALESSANDRA;SCALCON, VALERIA;CITTA, ANNA;BINDOLI, ALBERTO;RIGOBELLO, MARIA PIA;
2015
Abstract
Three new compounds containing the bis(triphenylphosphane)iminium cation (PPN+) with ClO4 −, BF4− and[AgCl2]− as counter anions have been synthesized and structurally characterized. The two derivatives with ClO4− and BF4− were found to be isostructural by single crystal X-ray diffraction. Interestingly, the three compounds show extremely potent antiproliferative effects against the human cancer cell line SKOV3. To gain insights into the possible mechanisms of biological action, several intracellular targets have been considered. Thus, DNA binding has been evaluated, as well as the effects of the compounds on the mitochondrial function. Furthermore, the compounds have been tested as possible inhibitors of the seleno-enzyme thioredoxin reductase.File | Dimensione | Formato | |
---|---|---|---|
Insights into the strong in-vitro anticancer effects for bis(triphenylphosphane)iminium_ 2015.pdf
accesso aperto
Descrizione: PDF
Tipologia:
Postprint (accepted version)
Licenza:
Accesso libero
Dimensione
1.48 MB
Formato
Adobe PDF
|
1.48 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.